Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Graft-Versus-Host Disease Impairs Early B Lymphopoiesis in the Bone Marrow

Kristina Doser, PhD, Tina J Boeld, PhD, Martin Heidenreich, Reinhard Andreesen, MD, PhD, Petra Hoffmann, PhD, Matthias Edinger, MD

Blood (2011) 118 (21): 2976.

https://doi.org/10.1182/blood.V118.21.2976.2976

Published: 2011

Journal Articles

Efficient Treatment of Murine Acute Graft-Versus-Host Disease with In Vitro Expanded CD4 + CD25 + Regulatory T Cells

Tina J Boeld, PhD, Kristina Doser, PhD, Corinna Lang-Schwarz, MD, Elisabeth Huber, MD, Reinhard Andreesen, MD, PhD, Petra Hoffmann, PhD, Matthias Edinger, MD

Blood (2011) 118 (21): 2987.

https://doi.org/10.1182/blood.V118.21.2987.2987

Published: 2011

Journal Articles

Genome-Wide Profiling of Epigenetic and Transcription Factor Regulation In Human Macrophage Differentiation

Thu-Hang Pham, Monika Lichtinger, Chris Benner, Sabine Pape, Lucia Schwarzfischer, Maja Klug, Andreas Gogol-Doering, Yuhui Hu, Reinhard Andreesen, MD, PhD, Wei Chen, Michael Rehli

Blood (2010) 116 (21): 3875.

https://doi.org/10.1182/blood.V116.21.3875.3875

Published: 2010

Journal Articles

Profiling of Aberrant DNA Methylation In AML Reveals Subclasses of CpG Islands with Epigenetic or Genetic Association

Claudia Gebhard, Mohammed Sadeh, Dagmar Glatz, Lucia Schwarzfischer, Rainer Spang, Gerhard Ehninger, Christian Thiede, MD, Reinhard Andreesen, MD, PhD, Michael Rehli

Blood (2010) 116 (21): 2498.

https://doi.org/10.1182/blood.V116.21.2498.2498

Published: 2010

Journal Articles

Compassionate Use of Combined Anti-Inflammatory and Angiostatic Treatment as Third-Line Therapy in Eight Patients with Multiple Myeloma – a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan.

Albrecht Reichle, Martin Vogelhuber, Ernst Holler, PhD, Joachim Hahn, Reinhard Andreesen, MD, PhD

Blood (2009) 114 (22): 4958.

https://doi.org/10.1182/blood.V114.22.4958.4958

Published: 2009

Journal Articles

“ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation”.

Karin Landfried, Martin Hausmann, Gerhard Rogler, Daniel Wolff, Anne M Dickinson, PhD, Matthew Collin, MD, PhD, Juergen Finke, Ernst Holler, PhD, Reinhard Andreesen, MD, PhD

Blood (2009) 114 (22): 1155.

https://doi.org/10.1182/blood.V114.22.1155.1155

Published: 2009

Journal Articles

Validation of the Lung Function Score as a Valuable Parameter for the Assessment of Chronic Graft-Versus-Host Disease and Clinical Outcome After Allogeneic Haematopoietic Cell Transplantation.

Diana Ditz, MD, Robert Rabanus, MD, Christian Schulz, MD, PhD, Daniel Wolff, MD, PhD, Reinhard Andreesen, MD, PhD, Ernst Holler, MD, PhD, Gerhard Hildebrandt, MD, PhD

Blood (2009) 114 (22): 2259.

https://doi.org/10.1182/blood.V114.22.2259.2259

Published: 2009

Journal Articles

In Vitro Monitoring of Defibrotide Prophylaxis for Endothelial Complications Following Allogeneic Stem Cell Transplantation.

Gunther Eissner, PhD, Julia Wiesner, Nancy Hahn, Massimo Iacobelli, MD, Marion Haubitz, MD, Reinhard Andreesen, MD,PhD, Ernst Holler, MD,PhD

Blood (2006) 108 (11): 2969.

https://doi.org/10.1182/blood.V108.11.2969.2969

Published: 2006

Journal Articles

Is Survivin a Possible Target Antigen for Cellular Immunotherapy in Multiple Myeloma?.

Matthias Grube, MD, Stephanie Moritz, Ellen Obermann, MD, Katayoun Rezvani, MD, PhD, Andreas Mackensen, MD, PhD, Reinhard Andreesen, MD, PhD, Ernst Holler, MD, PhD

Blood (2005) 106 (11): 5145.

https://doi.org/10.1182/blood.V106.11.5145.5145

Published: 2005

Journal Articles

Oligotide, a Defibrotide Derivative, Protects Human Microvascular Endothelial Cells Against Fludarabine-Induced Activation, Damage and Allogenicity.

Guenther Eissner, PhD, Massimo Iacobelli, MD, Susanna Blueml, Reinhard Andreesen, MD, PhD, Ernst Holler, MD, PhD

Blood (2004) 104 (11): 4942.

https://doi.org/10.1182/blood.V104.11.4942.4942

Published: 2004

NARROW

Graft-Versus-Host Disease Impairs Early B Lymphopoiesis in the Bone Marrow

Efficient Treatment of Murine Acute Graft-Versus-Host Disease with In Vitro Expanded CD4 + CD25 + Regulatory T Cells

Genome-Wide Profiling of Epigenetic and Transcription Factor Regulation In Human Macrophage Differentiation

Profiling of Aberrant DNA Methylation In AML Reveals Subclasses of CpG Islands with Epigenetic or Genetic Association

Compassionate Use of Combined Anti-Inflammatory and Angiostatic Treatment as Third-Line Therapy in Eight Patients with Multiple Myeloma – a Combined Treatment Setting of Lenalidomide with Pioglitazone, Dexamethasone and Low-Dose Treosulfan.

“ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation”.

Validation of the Lung Function Score as a Valuable Parameter for the Assessment of Chronic Graft-Versus-Host Disease and Clinical Outcome After Allogeneic Haematopoietic Cell Transplantation.

In Vitro Monitoring of Defibrotide Prophylaxis for Endothelial Complications Following Allogeneic Stem Cell Transplantation.

Is Survivin a Possible Target Antigen for Cellular Immunotherapy in Multiple Myeloma?.

Oligotide, a Defibrotide Derivative, Protects Human Microvascular Endothelial Cells Against Fludarabine-Induced Activation, Damage and Allogenicity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only